You are here

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35233 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Overactive Bladder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
65 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- male or female subjects 65 years of age or older

- OAB symptoms for at least 3 months

- score 3 or greater on Vulnerable Elderly Survey (VES-13)

- adequate mobility for independent toileting

- mean number of at least 2 UUI episodes per 24 hours

- mean urinary frequency of 8 or more micturitions per 24 hours

- able to independently complete the bladder diaries

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- PVR urinary volume greater than 200 ml

- MMSE score less than 20

- greater than 15 UUI episodes per 24 hours

- creatinine clearance less than 30 ml/min

- an average resting heart rate of greater than or equal to 90 beats per minute

NCT00928070
Pfizer
Completed
A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Overactive Bladder
NCT00879398
All Genders
18+
Years
Multiple Sites
Overactive Bladder (OAB)
NCT00282932
Males
40+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now